CoChat

Matrix stiffness may drive multi-cellular crosstalk via YAP signaling in biliary atresia liver fibrosis: a mechanistic review

Open access
Cheng, Jiwen · 2026 · Frontiers in Cell and Developmental Biology

The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.

Abstract

Background: Biliary atresia (BA) is a devastating liver disease in infants. It leads to progressive cholangitis and fibrosis. In BA, the liver builds up too much extracellular matrix (ECM) and crosslinks it. That makes the tissue stiffer over time—a physical hallmark of fibrosis. Mechanistic Framework: Most of the current evidence comes from non-BA models and lab studies. Those studies hint that higher matrix stiffness might act as a mechanical trigger. It could activate YAP signaling, which then organizes pathological crosstalk among hepatocytes, cholangiocytes, and hepatic stellate cells (HSCs). Direct proof from BA tissue is still missing. Key Findings: This review looks at how matrix stiffness—through YAP-driven mechanotransduction—may drive pro-fibrotic changes in hepatocytes, cholangiocytes, and HSCs. We propose a self-reinforcing, multi-cellular pro-fibrotic network: stiff ECM turns on YAP in hepatocytes (which release inflammatory signals) and cholangiocytes (which secrete pro-fibrotic factors). Those activated HSCs then deposit and crosslink even more ECM. That raises stiffness further and locks YAP activation in all 3 cell types. Right now, this model rests mostly on indirect evidence. It needs BA-specific testing. Therapeutic Implications: We also touch on new strategies that target this mechanobiological circuit—YAP inhibitors and matrix-softening methods. Conclusion: By pulling together what we know about ECM mechanics, YAP mechanotransduction, and cell-cell crosstalk, this review points to the matrix stiffness–YAP axis as a likely key driver of BA fibrosis. It also looks like a promising treatment target.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fcell.2026.1842681

Cites

75 of 75 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIGURE 1 YAP mechanotransduction and the multi-cellular profibrotic network. (A) Mechanotransduction of matrix stiffness. Stiff ECM is sensed by integrins, activating the FAK–Rho/ROCK pathway and promoting actin stress fiber formation. Cytoskeletal tension is transmitted to the nucleus via the LINC complex, facilitating YAP nuclear translocation. Nuclear YAP binds TEAD to drive pro-proliferative and pro-fibrotic gene expression. (B) Matrix stiffness–YAP axis establishes a multi-cellular profibrotic network. Increased matrix stiffness activates YAP in hepatocytes, cholangiocytes, and HSCs. Activated hepatocytes secrete CYR61 (dashed arrow, hypothetical in BA), recruiting macrophages and promoting inflammation. Activated cholangiocytes secrete PDGF, CTGF, and TGF-β (solid arrows, supported by non-BA evidence), which activate HSCs. Activated HSCs deposit stiff ECM, further increasing matrix stiffness and reinforcing YAP activation in all 3 cell types. Solid arrows: pathways with experimental support in non-BA models; dashed arrows: pathways requiring BA-specific validation.
FIGURE 1 YAP mechanotransduction and the multi-cellular profibrotic network. (A) Mechanotransduction of matrix stiffness. Stiff ECM is sensed by integrins, activating the FAK–Rho/ROCK pathway and promoting actin stress fiber formation. Cytoskeletal tension is transmitted to the nucleus via the LINC complex, facilitating YAP nuclear translocation. Nuclear YAP binds TEAD to drive pro-proliferative and pro-fibrotic gene expression. (B) Matrix stiffness–YAP axis establishes a multi-cellular profibrotic network. Increased matrix stiffness activates YAP in hepatocytes, cholangiocytes, and HSCs. Activated hepatocytes secrete CYR61 (dashed arrow, hypothetical in BA), recruiting macrophages and promoting inflammation. Activated cholangiocytes secrete PDGF, CTGF, and TGF-β (solid arrows, supported by non-BA evidence), which activate HSCs. Activated HSCs deposit stiff ECM, further increasing matrix stiffness and reinforcing YAP activation in all 3 cell types. Solid arrows: pathways with experimental support in non-BA models; dashed arrows: pathways requiring BA-specific validation.CC BY · PubMed Central
FIGURE 2 Hypothetical stage-specific therapeutic interventions targeting the matrix stiffness–YAP axis. Interventions are classified into YAP/TAZ inhibition (Class I) and matrix mechanical microenvironment modulation (Class II). A speculative timeline (preoperative, early postoperative, late postoperative) is shown to illustrate how different strategies might be aligned with disease stages. Dashed boxes denote purely hypothetical interventions that have not been validated in BA models. References for each intervention are provided where available (e.g., verteporfin: Zhu et al., 2026; LOX inhibitors; Leung et al., 2023; statins; Russell and Camargo, 2022).
FIGURE 2 Hypothetical stage-specific therapeutic interventions targeting the matrix stiffness–YAP axis. Interventions are classified into YAP/TAZ inhibition (Class I) and matrix mechanical microenvironment modulation (Class II). A speculative timeline (preoperative, early postoperative, late postoperative) is shown to illustrate how different strategies might be aligned with disease stages. Dashed boxes denote purely hypothetical interventions that have not been validated in BA models. References for each intervention are provided where available (e.g., verteporfin: Zhu et al., 2026; LOX inhibitors; Leung et al., 2023; statins; Russell and Camargo, 2022).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 75 references

Cited by

Still being checked.

Metadata

Authors
Cheng, J.
Affiliations
First Affiliated Hospital of Xi'an Jiaotong University (CN)
Corresponding author
Cheng, Jiwen
Venue
Frontiers in Cell and Developmental Biology
Published
2026-07-01
Volume
14
Pages
1842681-1842681
ISSN
2296-634X (ISSN-L)
OpenAlex
W7166826835
Cited by
0
References
75
FWCI
0.00
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Cell and Developmental Biology (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
National Natural Science Foundation of China (81800450)
Topics
  • Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hippo pathway signaling and YAP/TAZ
Keywords
biliary atresia, liver fibrosis, extracellular matrix stiffness, YAP signaling, mechanotransduction, hepatic stellate cells, cholangiocytes, hepatocytes, YAP inhibitor, matrix softening

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Matrix stiffness may drive multi-cellular crosstalk via YAP signaling in biliary atresia liver fibrosis: a mechanistic review. https://app.cochat.ai/papers/10.3389/fcell.2026.1842681
The paper
Cheng, J. (2026). Matrix stiffness may drive multi-cellular crosstalk via YAP signaling in biliary atresia liver fibrosis: a mechanistic review. Frontiers in Cell and Developmental Biology. https://doi.org/10.3389/fcell.2026.1842681

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.